| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | deaminase binding | 8.09e-10 | 4 | 108 | 4 | GO:1990827 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 1.06e-06 | 15 | 108 | 4 | GO:1990247 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SP1 ZNF486 ZNF48 FEZF2 MTF2 ESR2 NSD1 ZNF195 ZNF75CP ZFP37 ZNF404 ZNF23 ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 2.68e-06 | 1459 | 108 | 23 | GO:0000977 |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 7.91e-06 | 24 | 108 | 4 | GO:0140517 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 9.38e-06 | 25 | 108 | 4 | GO:0070034 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SP1 ZNF486 ZNF48 FEZF2 ESR2 ZNF195 ZNF75CP ZFP37 ZNF404 ZNF23 ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 1.91e-05 | 1412 | 108 | 21 | GO:0000981 |
| GeneOntologyMolecularFunction | hemoglobin beta binding | 2.90e-05 | 2 | 108 | 2 | GO:0031722 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 3.31e-05 | 34 | 108 | 4 | GO:0008266 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 5.75e-05 | 39 | 108 | 4 | GO:0008187 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SP1 ZNF486 ZNF48 FEZF2 ESR2 NSD1 ZNF195 ZNF75CP ZNF23 ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF221 ZNF30 ZNF107 ZNF418 ZNF445 | 1.17e-04 | 1244 | 108 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SP1 ZNF486 ZNF48 FEZF2 ESR2 NSD1 ZNF195 ZNF75CP ZNF23 ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF221 ZNF30 ZNF107 ZNF418 ZNF445 | 1.53e-04 | 1271 | 108 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RPS6KA4 HTATIP2 CDKL3 DYRK4 CIT TTBK2 CLK1 EIF2AK4 PRKDC STK25 | 1.54e-04 | 446 | 108 | 10 | GO:0004674 |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.58e-04 | 363 | 108 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | hemoglobin alpha binding | 2.87e-04 | 5 | 108 | 2 | GO:0031721 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 3.43e-04 | 111 | 108 | 5 | GO:0003727 | |
| GeneOntologyMolecularFunction | haptoglobin binding | 1.27e-03 | 10 | 108 | 2 | GO:0031720 | |
| GeneOntologyMolecularFunction | protein kinase activity | RPS6KA4 HTATIP2 CDKL3 DYRK4 CIT TTBK2 CLK1 EIF2AK4 PRKDC STK25 | 1.54e-03 | 600 | 108 | 10 | GO:0004672 |
| GeneOntologyMolecularFunction | hemoglobin binding | 1.54e-03 | 11 | 108 | 2 | GO:0030492 | |
| GeneOntologyMolecularFunction | U3 snoRNA binding | 1.54e-03 | 11 | 108 | 2 | GO:0034511 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CERK RPS6KA4 HTATIP2 CDKL3 DYRK4 CIT TTBK2 CLK1 EIF2AK4 PRKDC STK25 | 1.59e-03 | 709 | 108 | 11 | GO:0016773 |
| GeneOntologyMolecularFunction | co-SMAD binding | 1.85e-03 | 12 | 108 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | chromatin binding | MCM8 FEZF2 MTF2 ESR2 NSD1 REPIN1 HNRNPC DDX1 CHD5 NIPBL ZNF445 | 2.20e-03 | 739 | 108 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | oxygen carrier activity | 2.53e-03 | 14 | 108 | 2 | GO:0005344 | |
| GeneOntologyMolecularFunction | 5S rRNA binding | 2.53e-03 | 14 | 108 | 2 | GO:0008097 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.80e-03 | 52 | 108 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | kinase activity | CERK RPS6KA4 HTATIP2 CDKL3 DYRK4 CIT TTBK2 CLK1 EIF2AK4 PRKDC STK25 | 2.84e-03 | 764 | 108 | 11 | GO:0016301 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 9.81e-09 | 6 | 106 | 4 | GO:0090367 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 2.28e-08 | 7 | 106 | 4 | GO:0090365 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomerase | 7.67e-06 | 25 | 106 | 4 | GO:0032211 | |
| GeneOntologyBiologicalProcess | mRNA modification | 9.03e-06 | 26 | 106 | 4 | GO:0016556 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.86e-05 | 31 | 106 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 2.40e-05 | 33 | 106 | 4 | GO:1904357 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 4.80e-05 | 77 | 106 | 5 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation by eIF2 alpha phosphorylation | 5.74e-05 | 15 | 106 | 3 | GO:0010998 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 6.35e-05 | 42 | 106 | 4 | GO:0032205 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA biosynthetic process | 6.97e-05 | 43 | 106 | 4 | GO:2000279 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 8.62e-05 | 87 | 106 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 9.10e-05 | 88 | 106 | 5 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation in response to stress | 1.02e-04 | 18 | 106 | 3 | GO:0043558 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.07e-04 | 91 | 106 | 5 | GO:0006446 | |
| GeneOntologyBiologicalProcess | regulation of eIF2 alpha phosphorylation by heme | 1.56e-04 | 4 | 106 | 2 | GO:0010999 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 1.75e-04 | 101 | 106 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | chromosome organization | HNRNPCL1 MCM8 MCMDC2 CIT HNRNPC DDX1 HNRNPCL3 BRCA2 CDK5RAP2 PRKDC NIPBL HNRNPCL2 | 2.11e-04 | 686 | 106 | 12 | GO:0051276 |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 2.29e-04 | 107 | 106 | 5 | GO:2001251 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 2.33e-04 | 168 | 106 | 6 | GO:0000723 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 2.58e-04 | 60 | 106 | 4 | GO:0032210 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 3.20e-04 | 115 | 106 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of translation in response to stress | 3.94e-04 | 28 | 106 | 3 | GO:0043555 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 4.41e-04 | 69 | 106 | 4 | GO:1904356 | |
| GeneOntologyBiologicalProcess | telomere organization | 5.73e-04 | 199 | 106 | 6 | GO:0032200 | |
| GeneOntologyBiologicalProcess | translational initiation | 6.01e-04 | 132 | 106 | 5 | GO:0006413 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 9.30e-09 | 6 | 106 | 4 | GO:1990826 | |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 7.28e-06 | 25 | 106 | 4 | GO:0005697 | |
| GeneOntologyCellularComponent | pronucleus | 1.16e-05 | 28 | 106 | 4 | GO:0045120 | |
| Domain | - | SP1 ZNF486 ZNF48 FEZF2 ZNF195 REPIN1 ZFP37 ZNF404 ZNF23 GTF3A ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 1.58e-10 | 679 | 105 | 21 | 3.30.160.60 |
| Domain | zf-C2H2 | SP1 ZNF486 ZNF48 FEZF2 ZNF195 REPIN1 ZFP37 ZNF404 ZNF23 GTF3A ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 2.29e-10 | 693 | 105 | 21 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | SP1 ZNF486 ZNF48 FEZF2 ZNF195 REPIN1 ZFP37 ZNF404 ZNF23 GTF3A ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 2.35e-10 | 694 | 105 | 21 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | SP1 ZNF486 ZNF48 FEZF2 ZNF195 REPIN1 ZFP37 ZNF404 ZNF23 GTF3A ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 1.72e-09 | 775 | 105 | 21 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | SP1 ZNF486 ZNF48 FEZF2 ZNF195 REPIN1 ZFP37 ZNF404 ZNF23 GTF3A ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 1.80e-09 | 777 | 105 | 21 | PS00028 |
| Domain | zf-C2H2_6 | ZNF486 ZNF48 FEZF2 ZNF195 ZFP37 ZNF404 ZNF253 ZNF727 ZNF799 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 2.51e-09 | 314 | 105 | 14 | PF13912 |
| Domain | Znf_C2H2-like | SP1 ZNF486 ZNF48 FEZF2 ZNF195 REPIN1 ZFP37 ZNF404 ZNF23 GTF3A ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 2.77e-09 | 796 | 105 | 21 | IPR015880 |
| Domain | Znf_C2H2 | SP1 ZNF486 ZNF48 FEZF2 ZNF195 REPIN1 ZFP37 ZNF404 ZNF23 GTF3A ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 3.38e-09 | 805 | 105 | 21 | IPR007087 |
| Domain | ZnF_C2H2 | SP1 ZNF486 ZNF48 FEZF2 ZNF195 REPIN1 ZFP37 ZNF404 ZNF23 GTF3A ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 3.61e-09 | 808 | 105 | 21 | SM00355 |
| Domain | KRAB | ZNF486 ZNF195 ZFP37 ZNF404 ZNF23 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF418 ZNF443 ZNF445 | 1.33e-08 | 358 | 105 | 14 | PS50805 |
| Domain | hnRNP_C | 1.40e-08 | 6 | 105 | 4 | IPR017347 | |
| Domain | KRAB | ZNF486 ZNF195 ZFP37 ZNF404 ZNF23 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF418 ZNF443 ZNF445 | 1.95e-08 | 369 | 105 | 14 | SM00349 |
| Domain | KRAB | ZNF486 ZNF195 ZFP37 ZNF404 ZNF23 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF418 ZNF443 ZNF445 | 2.02e-08 | 370 | 105 | 14 | IPR001909 |
| Domain | KRAB | ZNF486 ZNF195 ZFP37 ZNF404 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF418 ZNF443 ZNF445 | 1.08e-07 | 358 | 105 | 13 | PF01352 |
| Domain | Haemoglobin_b | 3.10e-04 | 5 | 105 | 2 | IPR002337 | |
| Domain | S_TKc | 9.52e-04 | 359 | 105 | 8 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.00e-03 | 362 | 105 | 8 | PS00108 | |
| Domain | MCM | 1.10e-03 | 9 | 105 | 2 | SM00350 | |
| Domain | MCM_dom | 1.10e-03 | 9 | 105 | 2 | IPR001208 | |
| Domain | MCM | 1.10e-03 | 9 | 105 | 2 | IPR031327 | |
| Domain | MCM | 1.10e-03 | 9 | 105 | 2 | PF00493 | |
| Domain | Protein_kinase_ATP_BS | 1.35e-03 | 379 | 105 | 8 | IPR017441 | |
| Domain | Pkinase | 1.39e-03 | 381 | 105 | 8 | PF00069 | |
| Domain | Globin | 1.99e-03 | 12 | 105 | 2 | IPR000971 | |
| Domain | Globin | 1.99e-03 | 12 | 105 | 2 | PF00042 | |
| Domain | GLOBIN | 1.99e-03 | 12 | 105 | 2 | PS01033 | |
| Domain | ZINC_PROTEASE | 2.27e-03 | 98 | 105 | 4 | PS00142 | |
| Domain | - | 2.35e-03 | 13 | 105 | 2 | 1.10.490.10 | |
| Domain | Globin/Proto | 2.35e-03 | 13 | 105 | 2 | IPR012292 | |
| Domain | Kinase-like_dom | 3.48e-03 | 542 | 105 | 9 | IPR011009 | |
| Domain | Globin-like | 3.57e-03 | 16 | 105 | 2 | IPR009050 | |
| Domain | Ser/Thr_kinase_AS | 4.04e-03 | 357 | 105 | 7 | IPR008271 | |
| Domain | PROTEIN_KINASE_ATP | 4.37e-03 | 459 | 105 | 8 | PS00107 | |
| Domain | PLAC | 5.03e-03 | 19 | 105 | 2 | PS50900 | |
| Domain | PLAC | 5.03e-03 | 19 | 105 | 2 | IPR010909 | |
| Domain | TSP_1 | 5.37e-03 | 63 | 105 | 3 | PF00090 | |
| Domain | TSP1 | 5.86e-03 | 65 | 105 | 3 | SM00209 | |
| Domain | TSP1_rpt | 5.86e-03 | 65 | 105 | 3 | IPR000884 | |
| Domain | TSP1 | 5.86e-03 | 65 | 105 | 3 | PS50092 | |
| Domain | Zinc_finger_PHD-type_CS | 5.86e-03 | 65 | 105 | 3 | IPR019786 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 1.06e-05 | 25 | 79 | 4 | MM15606 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.06e-05 | 25 | 79 | 4 | MM15608 | |
| Pathway | REACTOME_HEME_SIGNALING | 4.65e-05 | 13 | 79 | 3 | MM15685 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 5.24e-05 | 37 | 79 | 4 | MM15683 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 3.08e-04 | 58 | 79 | 4 | MM15149 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | SP1 USP9X ESR2 ZNF195 ZFP37 ZNF23 CYCS ZNF727 ZNF799 ZNF221 ZNF107 ZNF418 ZNF445 | 3.15e-04 | 768 | 79 | 13 | MM14851 |
| Pubmed | 9.13e-11 | 4 | 109 | 4 | 23831410 | ||
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 9.13e-11 | 4 | 109 | 4 | 35729324 | |
| Pubmed | 9.13e-11 | 4 | 109 | 4 | 36681355 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 9.13e-11 | 4 | 109 | 4 | 10805751 | |
| Pubmed | Interaction between nucleosome assembly protein 1-like family members. | 2.14e-10 | 12 | 109 | 5 | 21333655 | |
| Pubmed | 4.55e-10 | 5 | 109 | 4 | 29846695 | ||
| Pubmed | 4.55e-10 | 5 | 109 | 4 | 9128719 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 4.55e-10 | 5 | 109 | 4 | 25809670 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HNRNPCL1 RPS6KA4 RPS2 LARP1 PFN1 HNRNPC DDX1 HNRNPCL3 JPH1 TSR1 CHD5 HNRNPCL4 HADHA PRKDC HBB HBD RPL7 HNRNPCL2 | 9.71e-10 | 949 | 109 | 18 | 36574265 |
| Pubmed | 1.36e-09 | 6 | 109 | 4 | 26048669 | ||
| Pubmed | Selective disruption of genes expressed in totipotent embryonal stem cells. | 1.36e-09 | 6 | 109 | 4 | 1317320 | |
| Pubmed | 1.36e-09 | 6 | 109 | 4 | 15687492 | ||
| Pubmed | 1.36e-09 | 6 | 109 | 4 | 18363099 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 25846207 | ||
| Pubmed | 1.14e-08 | 9 | 109 | 4 | 10452948 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 4.28e-08 | 226 | 109 | 9 | 37839992 | |
| Pubmed | The biogenesis of the coiled body during early mouse development. | 4.43e-08 | 12 | 109 | 4 | 7768196 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HNRNPCL1 ZNF48 NSD1 LARP1 HNRNPC DDX1 HNRNPCL3 BRCA2 ZSCAN21 CYCS CD63 PRKDC HBB HBD NIPBL HNRNPCL2 | 4.99e-08 | 954 | 109 | 16 | 36373674 |
| Pubmed | HNRNPCL1 RPS2 USP9X LARP1 USP9Y PFN1 HNRNPC DDX1 GLB1 TSR1 CHD5 HADHA PRKDC SCFD1 KRT37 RPL7 SPATA13 | 1.16e-07 | 1153 | 109 | 17 | 29845934 | |
| Pubmed | A method to identify cDNAs based on localization of green fluorescent protein fusion products. | 2.11e-07 | 17 | 109 | 4 | 10716735 | |
| Pubmed | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. | 4.71e-07 | 49 | 109 | 5 | 27352031 | |
| Pubmed | HNRNPCL1 NRDC RPS2 INPP4A USP9X LARP1 GRIA2 PFN1 CIT HNRNPC DDX1 HNRNPCL3 CYCS HADHA HBB HBD RPL7 HNRNPCL2 | 4.90e-07 | 1431 | 109 | 18 | 37142655 | |
| Pubmed | SCN11A HNRNPCL1 LARP1 GRIA2 HNRNPC DDX1 FER1L6 HNRNPCL3 STARD9 H4C7 CHD5 CYCS EIF2AK4 HADHA PRKDC NIPBL HNRNPCL2 SPATA13 | 5.47e-07 | 1442 | 109 | 18 | 35575683 | |
| Pubmed | 1.08e-06 | 244 | 109 | 8 | 28902428 | ||
| Pubmed | 1.29e-06 | 109 | 109 | 6 | 29511296 | ||
| Pubmed | Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. | 1.29e-06 | 26 | 109 | 4 | 15890332 | |
| Pubmed | 1.75e-06 | 181 | 109 | 7 | 37372979 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | HNRNPCL1 RPS6KA4 USP9X LAMA1 CDKL3 LARP1 DYRK4 PFN1 HNRNPC CLK1 AKAP11 ZNF30 | 1.98e-06 | 695 | 109 | 12 | 23602568 |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 2.42e-06 | 190 | 109 | 7 | 15161933 | |
| Pubmed | RPS2 LARP1 USP9Y REPIN1 HNRNPC DDX1 PGM3 TSR1 HADHA PRKDC HSD17B11 RPL7 | 3.05e-06 | 725 | 109 | 12 | 27025967 | |
| Pubmed | 3.54e-06 | 10 | 109 | 3 | 18765668 | ||
| Pubmed | 4.69e-06 | 397 | 109 | 9 | 21319273 | ||
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 6.21e-06 | 82 | 109 | 5 | 30274258 | |
| Pubmed | HNRNPCL1 MCM8 NRDC LARP1 DDX1 HNRNPCL3 GLB1 TSR1 HNRNPCL4 EIF2AK4 HSD17B11 | 6.54e-06 | 650 | 109 | 11 | 38777146 | |
| Pubmed | NRDC NSD1 REPIN1 ZFP37 TTBK2 ZSCAN21 TSR1 ATRNL1 CDK5RAP2 EIF2AK4 TYW1 TSTD2 STK25 ZNF445 | 7.69e-06 | 1084 | 109 | 14 | 11544199 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GBF1 NRDC RPS2 USP9X LARP1 PFN1 HNRNPC DDX1 TSR1 STARD9 CYCS HADHA PRKDC SCFD1 NIPBL RPL7 | 9.53e-06 | 1425 | 109 | 16 | 30948266 |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 37902616 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 270684 | ||
| Pubmed | Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. | 9.73e-06 | 2 | 109 | 2 | 21099112 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11121056 | ||
| Pubmed | Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. | 9.73e-06 | 2 | 109 | 2 | 9525578 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 14675418 | ||
| Pubmed | Nucleotide sequences of the mouse globin beta gene cDNAs in a wild derived new haplotype Hbb(w1). | 9.73e-06 | 2 | 109 | 2 | 10441738 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 32344432 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 31562377 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16803575 | ||
| Pubmed | The adult beta-globin genes of the "single" type mouse C57BL. | 9.73e-06 | 2 | 109 | 2 | 7237554 | |
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 9.73e-06 | 2 | 109 | 2 | 12895410 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 27245334 | ||
| Pubmed | Co-inheritance of alpha- and beta-thalassaemia in mice ameliorates thalassaemic phenotype. | 9.73e-06 | 2 | 109 | 2 | 17493845 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28641125 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8524813 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25616571 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 35863436 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23074246 | ||
| Pubmed | High phosphate intake induces bone loss in nephrectomized thalassemic mice. | 9.73e-06 | 2 | 109 | 2 | 35622784 | |
| Pubmed | A humanized mouse model for a common beta0-thalassemia mutation. | 9.73e-06 | 2 | 109 | 2 | 15780748 | |
| Pubmed | Evolution of the mouse beta-globin genes: a recent gene conversion in the Hbbs haplotype. | 9.73e-06 | 2 | 109 | 2 | 3870864 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11860449 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12127975 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24817273 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8041612 | ||
| Pubmed | A 66-base pair insert bridges the deletion responsible for a mouse model of beta-thalassemia. | 9.73e-06 | 2 | 109 | 2 | 3017971 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8922996 | ||
| Pubmed | Intervening sequence of DNA identified in the structural portion of a mouse beta-globin gene. | 9.73e-06 | 2 | 109 | 2 | 273235 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 35396390 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 36214153 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 728996 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23157711 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19609526 | ||
| Pubmed | Discovery of a new HBB haplotype w2 in a wild-derived house mouse, Mus musculus. | 9.73e-06 | 2 | 109 | 2 | 18299925 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 2991851 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 6086313 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22203977 | ||
| Pubmed | ERβ-dependent effects on uterine endothelial cells are cell specific and mediated via Sp1. | 9.73e-06 | 2 | 109 | 2 | 23756706 | |
| Pubmed | A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia. | 9.73e-06 | 2 | 109 | 2 | 16631345 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12480689 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 482942 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11830454 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11154217 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 6736028 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12925892 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24780610 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21194254 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18603555 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 264241 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11418464 | ||
| Pubmed | Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S. | 9.73e-06 | 2 | 109 | 2 | 21304105 | |
| Pubmed | In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia. | 9.73e-06 | 2 | 109 | 2 | 30422819 | |
| Pubmed | β-Globin cis-elements determine differential nuclear targeting through epigenetic modifications. | 9.73e-06 | 2 | 109 | 2 | 24297746 | |
| Pubmed | Cloning and amplification of alpha and beta mouse globin gene sequences synthesised in vitro. | 9.73e-06 | 2 | 109 | 2 | 338418 | |
| Pubmed | Nephrectomy Does not Exacerbate Cancellous Bone loss in Thalassemic Mice. | 9.73e-06 | 2 | 109 | 2 | 32385316 | |
| Pubmed | The evolution and sequence comparison of two recently diverged mouse chromosomal beta--globin genes. | 9.73e-06 | 2 | 109 | 2 | 519759 | |
| Pubmed | Humanized beta-thalassemia mouse model containing the common IVSI-110 splicing mutation. | 9.73e-06 | 2 | 109 | 2 | 16421096 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 7935410 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11877258 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 3428512 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 1820025 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22767512 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15820143 | ||
| Interaction | HNRNPCL3 interactions | 1.04e-07 | 23 | 104 | 5 | int:HNRNPCL3 | |
| Interaction | TRIM28 interactions | ZNF486 RPS2 HTATIP2 ZNF195 LARP1 GRIA2 CIT HNRNPC PGM3 GLB1 BRCA2 ZNF253 CYCS ZNF264 ZNF799 HADHA PRKDC SCFD1 ZNF30 ZNF107 ZNF418 NIPBL ZNF443 ZNF445 | 3.54e-07 | 1474 | 104 | 24 | int:TRIM28 |
| Interaction | CLK3 interactions | 2.09e-06 | 220 | 104 | 9 | int:CLK3 | |
| Interaction | CUL9 interactions | 2.94e-06 | 171 | 104 | 8 | int:CUL9 | |
| Interaction | TNIP1 interactions | HNRNPCL1 RPS6KA4 RPS2 LARP1 PFN1 HNRNPC DDX1 HNRNPCL3 JPH1 GLB1 TSR1 CHD5 HNRNPCL4 HADHA PRKDC SCFD1 HBB HBD RPL7 HNRNPCL2 | 3.51e-06 | 1217 | 104 | 20 | int:TNIP1 |
| Interaction | CLK2 interactions | 7.75e-06 | 195 | 104 | 8 | int:CLK2 | |
| Interaction | TMPO interactions | RPS2 ESR2 CIT HNRNPC DDX1 JPH1 CLK1 CDK5RAP2 EIF2AK4 TYW1 HADHA PRKDC SCFD1 HSD17B11 RPL7 | 8.39e-06 | 762 | 104 | 15 | int:TMPO |
| Interaction | DNAJC1 interactions | 1.76e-05 | 361 | 104 | 10 | int:DNAJC1 | |
| Interaction | RALYL interactions | 2.31e-05 | 66 | 104 | 5 | int:RALYL | |
| Interaction | KIF20A interactions | VWA8 RPS2 ESR2 LARP1 USP9Y CIT HNRNPC DDX1 HNRNPCL3 GLB1 H4C7 CDK5RAP2 HADHA PRKDC RPL7 HNRNPCL2 STK25 | 2.61e-05 | 1052 | 104 | 17 | int:KIF20A |
| Interaction | LMNA interactions | RPS2 NSD1 ZNF195 RETSAT CIT ABCA9 HNRNPC BRCA2 ZSCAN21 TSR1 CLK1 H4C7 CDK5RAP2 PRKDC SCFD1 HSD17B11 COA7 NIPBL KRT37 | 2.85e-05 | 1286 | 104 | 19 | int:LMNA |
| Interaction | FASN interactions | SP1 HNRNPCL1 GBF1 MCM8 MTF2 INPP4A USP9X ESR2 PFN1 CIT REPIN1 HNRNPC PGM3 HNRNPCL3 HSD17B11 NIPBL HNRNPCL2 | 2.94e-05 | 1062 | 104 | 17 | int:FASN |
| Interaction | REV1 interactions | 3.10e-05 | 35 | 104 | 4 | int:REV1 | |
| Interaction | DYRK2 interactions | 3.21e-05 | 173 | 104 | 7 | int:DYRK2 | |
| Interaction | KCNS3 interactions | 3.88e-05 | 37 | 104 | 4 | int:KCNS3 | |
| Interaction | CIT interactions | VWA8 RPS2 HCN1 ESR2 LARP1 CIT HNRNPC DDX1 HNRNPCL3 TSR1 H4C7 CDK5RAP2 HNRNPCL4 PRR14L HADHA PRKDC ZNF107 NIPBL RPL7 HNRNPCL2 | 4.52e-05 | 1450 | 104 | 20 | int:CIT |
| Interaction | SMC5 interactions | HNRNPCL1 ZNF48 NSD1 LARP1 HNRNPC DDX1 HNRNPCL3 BRCA2 ZSCAN21 CYCS CD63 PRKDC HBB HBD NIPBL HNRNPCL2 | 5.21e-05 | 1000 | 104 | 16 | int:SMC5 |
| Interaction | NEFM interactions | 5.83e-05 | 190 | 104 | 7 | int:NEFM | |
| Interaction | ANXA2 interactions | SP1 HNRNPCL1 RPS2 PFN1 CIT ABCA9 HNRNPC PRKDC NIPBL HNRNPCL2 | 6.21e-05 | 419 | 104 | 10 | int:ANXA2 |
| Interaction | NOTCH2 interactions | SP1 ZNF48 RPS2 ESR2 REPIN1 ZSCAN21 ZNF253 HSD17B11 ZNF107 ZNF445 | 6.72e-05 | 423 | 104 | 10 | int:NOTCH2 |
| Interaction | GPHN interactions | 6.87e-05 | 134 | 104 | 6 | int:GPHN | |
| Interaction | DCLRE1C interactions | 7.07e-05 | 43 | 104 | 4 | int:DCLRE1C | |
| Interaction | RAD21L1 interactions | 7.89e-05 | 3 | 104 | 2 | int:RAD21L1 | |
| Interaction | CHMP4B interactions | RPS2 USP9X CIT HNRNPC GLB1 BRCA2 H4C7 CDK5RAP2 AKAP11 HADHA PRKDC RPL7 HNRNPCL2 | 9.38e-05 | 727 | 104 | 13 | int:CHMP4B |
| Interaction | PTCD1 interactions | 9.48e-05 | 142 | 104 | 6 | int:PTCD1 | |
| Interaction | VRK1 interactions | 9.49e-05 | 277 | 104 | 8 | int:VRK1 | |
| Interaction | RPS27L interactions | 9.68e-05 | 206 | 104 | 7 | int:RPS27L | |
| Interaction | PPHLN1 interactions | 1.10e-04 | 146 | 104 | 6 | int:PPHLN1 | |
| Interaction | MGMT interactions | 1.14e-04 | 92 | 104 | 5 | int:MGMT | |
| Interaction | PRC1 interactions | GBF1 RPS2 ESR2 LARP1 CIT HNRNPC DDX1 GLB1 H4C7 CHD5 CDK5RAP2 HADHA PRKDC RPL7 HNRNPCL2 | 1.38e-04 | 973 | 104 | 15 | int:PRC1 |
| Interaction | MATR3 interactions | HNRNPCL1 RPS2 USP9X LARP1 USP9Y CIT HNRNPC DDX1 TSR1 EIF2AK4 PRKDC RPL7 | 1.42e-04 | 655 | 104 | 12 | int:MATR3 |
| Interaction | MCMDC2 interactions | 1.57e-04 | 4 | 104 | 2 | int:MCMDC2 | |
| Interaction | ZFP62 interactions | 1.62e-04 | 99 | 104 | 5 | int:ZFP62 | |
| Interaction | ZYG11A interactions | 1.66e-04 | 21 | 104 | 3 | int:ZYG11A | |
| Interaction | NBAS interactions | 1.86e-04 | 102 | 104 | 5 | int:NBAS | |
| Interaction | PRPF38A interactions | 1.88e-04 | 161 | 104 | 6 | int:PRPF38A | |
| Interaction | PHB1 interactions | VWA8 RPS2 ESR2 LARP1 USP9Y CIT REPIN1 HNRNPC DDX1 PGM3 TSR1 CYCS HADHA PRKDC HSD17B11 RPL7 | 2.01e-04 | 1123 | 104 | 16 | int:PHB1 |
| Interaction | BRCA1 interactions | SP1 GBF1 RPS6KA4 RPS2 USP9X ESR2 LARP1 PFN1 CIT HNRNPC DDX1 BRCA2 ZSCAN21 PRKDC NIPBL RPL7 REV1 | 2.14e-04 | 1249 | 104 | 17 | int:BRCA1 |
| Interaction | NCL interactions | SP1 ZNF48 RPS2 ESR2 PFN1 CIT JPH1 BRCA2 TSR1 CLK1 ABCC12 EIF2AK4 RPL7 | 2.35e-04 | 798 | 104 | 13 | int:NCL |
| Interaction | GTF3C2 interactions | 2.45e-04 | 169 | 104 | 6 | int:GTF3C2 | |
| Interaction | PPP1CA interactions | ESR2 LARP1 PFN1 CIT HNRNPC DDX1 AKAP11 EIF2AK4 HADHA PRKDC COA7 RPL7 | 2.48e-04 | 696 | 104 | 12 | int:PPP1CA |
| Interaction | HEXIM1 interactions | HNRNPCL1 RPS2 USP9X ESR2 USP9Y PFN1 HNRNPC DDX1 CHD5 HADHA PRKDC SCFD1 KRT37 RPL7 | 2.48e-04 | 913 | 104 | 14 | int:HEXIM1 |
| Interaction | ORC2 interactions | 2.65e-04 | 110 | 104 | 5 | int:ORC2 | |
| Interaction | RFC2 interactions | 2.87e-04 | 174 | 104 | 6 | int:RFC2 | |
| Interaction | ZNF746 interactions | 2.88e-04 | 326 | 104 | 8 | int:ZNF746 | |
| Interaction | HDAC6 interactions | GBF1 RPS2 USP9X ESR2 HTATIP2 LARP1 PFN1 DDX1 BRCA2 CYCS HADHA PRKDC HBD RPL7 | 2.96e-04 | 929 | 104 | 14 | int:HDAC6 |
| Interaction | CTCFL interactions | 2.97e-04 | 62 | 104 | 4 | int:CTCFL | |
| Interaction | KPNA3 interactions | 3.03e-04 | 248 | 104 | 7 | int:KPNA3 | |
| Interaction | CRNKL1 interactions | 3.14e-04 | 177 | 104 | 6 | int:CRNKL1 | |
| Interaction | IDE interactions | 3.44e-04 | 180 | 104 | 6 | int:IDE | |
| Interaction | EVA1C interactions | 3.56e-04 | 65 | 104 | 4 | int:EVA1C | |
| Interaction | RPS29 interactions | 3.64e-04 | 182 | 104 | 6 | int:RPS29 | |
| Interaction | STK38 interactions | 3.64e-04 | 182 | 104 | 6 | int:STK38 | |
| Interaction | CFAP251 interactions | 3.90e-04 | 6 | 104 | 2 | int:CFAP251 | |
| Interaction | FSBP interactions | 3.90e-04 | 6 | 104 | 2 | int:FSBP | |
| Interaction | HNRNPCL4 interactions | 3.90e-04 | 6 | 104 | 2 | int:HNRNPCL4 | |
| Interaction | MROH2B interactions | 3.90e-04 | 6 | 104 | 2 | int:MROH2B | |
| Interaction | NIFK interactions | 3.94e-04 | 431 | 104 | 9 | int:NIFK | |
| Interaction | RABL2A interactions | 3.98e-04 | 28 | 104 | 3 | int:RABL2A | |
| Interaction | PLXNA4 interactions | 3.98e-04 | 28 | 104 | 3 | int:PLXNA4 | |
| Interaction | EED interactions | RPS6KA4 MTF2 RPS2 USP9X ESR2 LAMA1 NSD1 PFN1 CIT HNRNPC DDX1 HADHA PRKDC SCFD1 HSD17B11 NIPBL RPL7 HNRNPCL2 | 4.03e-04 | 1445 | 104 | 18 | int:EED |
| Interaction | XAB2 interactions | 4.09e-04 | 186 | 104 | 6 | int:XAB2 | |
| Interaction | NPM1 interactions | SP1 RPS2 ESR2 NSD1 LARP1 GRIA2 PFN1 CIT HNRNPC DDX1 BRCA2 TSR1 CLK1 AKAP11 PRKDC RPL7 | 4.25e-04 | 1201 | 104 | 16 | int:NPM1 |
| Cytoband | 15q15.2 | 7.13e-06 | 16 | 109 | 3 | 15q15.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 4.32e-04 | 147 | 109 | 4 | chr15q15 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | SP1 ZNF486 ZNF48 FEZF2 ZNF195 REPIN1 ZFP37 ZNF404 ZNF23 GTF3A ZSCAN21 ZNF253 ZNF727 ZNF264 ZNF799 ZNF221 ZNF30 ZNF107 ZNF418 ZNF443 ZNF445 | 5.91e-13 | 718 | 74 | 21 | 28 |
| GeneFamily | MCM family | 5.84e-04 | 9 | 74 | 2 | 1085 | |
| GeneFamily | Hemoglobin subunits | 7.28e-04 | 10 | 74 | 2 | 940 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.70e-03 | 19 | 74 | 2 | 50 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN | 1.51e-05 | 37 | 106 | 4 | MM570 | |
| Coexpression | LEE_DIFFERENTIATING_T_LYMPHOCYTE | 1.80e-05 | 201 | 106 | 7 | M2200 | |
| Drug | vinylene | SP1 FEZF2 RPS2 NSD1 LGSN ZSCAN21 ZNF264 ZNF107 ZNF418 ZNF445 | 2.23e-07 | 245 | 106 | 10 | CID000006326 |
| Drug | nifedipine; Up 200; 10uM; MCF7; HG-U133A | 3.93e-07 | 199 | 106 | 9 | 603_UP | |
| Drug | 1,2,4-tribromobenzene | 9.74e-07 | 5 | 106 | 3 | CID000012002 | |
| Drug | tricapryl(methyl)ammonium | 2.15e-05 | 2 | 106 | 2 | CID011071504 | |
| Drug | allyl 2,4,6-tribromophenyl ether | 2.15e-05 | 2 | 106 | 2 | CID000076767 | |
| Drug | 1,3,5-tribromobenzene | 2.15e-05 | 2 | 106 | 2 | CID000012279 | |
| Drug | K 81 | 2.15e-05 | 2 | 106 | 2 | CID005744870 | |
| Drug | 2-(alpha-hydroxybenzyl)-benzimidazole | 2.15e-05 | 2 | 106 | 2 | CID000005792 | |
| Drug | NSC-334295 | 2.15e-05 | 2 | 106 | 2 | CID000100107 | |
| Drug | AC1L3OJQ | 2.15e-05 | 2 | 106 | 2 | CID000119294 | |
| Drug | pentabromobenzene | 2.15e-05 | 2 | 106 | 2 | CID000011854 | |
| Drug | tribromobenzene | 2.15e-05 | 2 | 106 | 2 | CID000011842 | |
| Drug | Bromkal 73-5 PE | 2.15e-05 | 2 | 106 | 2 | CID000118216 | |
| Drug | hydroxyethylretinamide | 2.32e-05 | 73 | 106 | 5 | CID006437840 | |
| Drug | ketononestrol aziridine | 2.71e-05 | 13 | 106 | 3 | CID000130642 | |
| Drug | ara-Hx | 3.39e-05 | 193 | 106 | 7 | CID000000804 | |
| Drug | AD 288 | 3.44e-05 | 14 | 106 | 3 | CID000073553 | |
| Drug | clofibrate; Down 200; 150uM; MCF7; HG-U133A | 3.86e-05 | 197 | 106 | 7 | 263_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; HL60; HG-U133A | 3.86e-05 | 197 | 106 | 7 | 1386_DN | |
| Drug | diacetyldeuteroheme | 4.28e-05 | 15 | 106 | 3 | CID004629150 | |
| Drug | mizolastine | 5.26e-05 | 16 | 106 | 3 | CID000065906 | |
| Drug | HBED | 5.26e-05 | 16 | 106 | 3 | CID000037336 | |
| Drug | furyl-dihydropyridine I | 6.42e-05 | 3 | 106 | 2 | CID000125806 | |
| Drug | pentabromoethylbenzene | 6.42e-05 | 3 | 106 | 2 | CID000006800 | |
| Drug | Nx-D | 6.42e-05 | 3 | 106 | 2 | CID006914638 | |
| Drug | mer13 | 6.42e-05 | 3 | 106 | 2 | CID000107453 | |
| Drug | BTBPE | 6.42e-05 | 3 | 106 | 2 | CID000037840 | |
| Drug | DNTB | 6.91e-05 | 216 | 106 | 7 | CID000015325 | |
| Drug | AC1L18ZJ | 7.61e-05 | 18 | 106 | 3 | CID000000324 | |
| Drug | Camptothecin | 1.16e-04 | 163 | 106 | 6 | ctd:D002166 | |
| Drug | 1q65 | 1.17e-04 | 54 | 106 | 4 | CID000448017 | |
| Drug | HPED | 1.28e-04 | 4 | 106 | 2 | CID000125856 | |
| Drug | 4-(2-carboxyvinyl)benzoic acid | 1.28e-04 | 4 | 106 | 2 | CID000089196 | |
| Drug | 1,4-dibromobenzene | 1.28e-04 | 4 | 106 | 2 | CID000007804 | |
| Drug | 3,3'-diClBPA | 1.28e-04 | 4 | 106 | 2 | CID000066238 | |
| Drug | AC1L4CDO | 1.28e-04 | 4 | 106 | 2 | CID000154482 | |
| Drug | PTU-23 | 1.28e-04 | 4 | 106 | 2 | CID000853760 | |
| Drug | AC1L9JVG | 1.28e-04 | 4 | 106 | 2 | CID000446603 | |
| Drug | griseoluteic acid | 1.28e-04 | 4 | 106 | 2 | CID000120266 | |
| Drug | 1,2,4,5-tetrabromobenzene | 1.28e-04 | 4 | 106 | 2 | CID000012486 | |
| Drug | potassium ferricyanide | 1.35e-04 | 56 | 106 | 4 | CID000026250 | |
| Drug | N,N-dimethylacrylamide | 1.42e-04 | 22 | 106 | 3 | CID000017587 | |
| Drug | tamoxifen aziridine | 1.42e-04 | 22 | 106 | 3 | CID003033894 | |
| Disease | Delta-Beta Thalassemia | 3.47e-05 | 3 | 101 | 2 | C0271985 | |
| Disease | beta thalassemia (implicated_via_orthology) | 3.47e-05 | 3 | 101 | 2 | DOID:12241 (implicated_via_orthology) | |
| Disease | hemoglobin measurement, hemoglobin A2 measurement | 1.15e-04 | 5 | 101 | 2 | EFO_0004509, EFO_0005845 | |
| Disease | hemoglobin E disease | 1.72e-04 | 6 | 101 | 2 | MONDO_0016243 | |
| Disease | Chloracne | 1.97e-04 | 33 | 101 | 3 | C0263454 | |
| Disease | anemia (biomarker_via_orthology) | 2.41e-04 | 7 | 101 | 2 | DOID:2355 (biomarker_via_orthology) | |
| Disease | neurexophilin-1 measurement | 3.20e-04 | 8 | 101 | 2 | EFO_0008244 | |
| Disease | microcephaly (is_implicated_in) | 3.20e-04 | 8 | 101 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | unipolar depression, response to bupropion, mood disorder | 1.91e-03 | 19 | 101 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | anti-Mullerian hormone measurement | 2.12e-03 | 20 | 101 | 2 | EFO_0004769 | |
| Disease | Primary microcephaly | 2.56e-03 | 22 | 101 | 2 | C0431350 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.56e-03 | 22 | 101 | 2 | C3711387 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.56e-03 | 22 | 101 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | breast cancer (implicated_via_orthology) | 3.31e-03 | 25 | 101 | 2 | DOID:1612 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFNDGSKGKLNHLCG | 236 | O95394 | |
| SKGKLNHLCGADFVK | 241 | O95394 | |
| KGGNLAASAKKKHGS | 1226 | Q8TDI0 | |
| GDHCKKFGGGKTERA | 396 | P07357 | |
| HKGKCIGSDEQLGKL | 281 | Q9P2K8 | |
| CIGSIQHLKSKFGKD | 1501 | Q8IUA7 | |
| KQEGGDGHCEGKNLK | 571 | Q8IVW4 | |
| SRIGKGGKACHKIFS | 41 | Q8N6S4 | |
| GKSSQRKGHKHGKSC | 381 | Q9UKA4 | |
| VDTGHCRGGQFKIKK | 16 | O95841 | |
| TAAKCKGLGAKVHTF | 76 | Q8NBQ5 | |
| IFEAVKGCHLFGAGK | 1681 | O14578 | |
| KISSKGHCQGDKSIF | 1056 | O95450 | |
| IGNSCGTKGHEAAKL | 416 | Q9UKP5 | |
| KGGCKNGYLRHTESK | 741 | Q96SN8 | |
| AFGKVVECIDHKAGG | 171 | P49759 | |
| GHKAKKPACKFEEGQ | 36 | Q9Y483 | |
| KGDLGLSKKCYEAGH | 1426 | Q96L73 | |
| HCQGFKSGGLRKKLH | 366 | Q96PE3 | |
| GCGINFNEKAIHKEG | 176 | P08962 | |
| QARLCAGKKGHGAEL | 131 | Q8TAT2 | |
| EDCQRGGQKKKGNKH | 236 | Q6PKG0 | |
| GKIAGCSVHKGFAFV | 41 | O60812 | |
| LGKGGAKCHRKVLSD | 11 | Q99525 | |
| GKIVGCSVHKGFAFV | 41 | P07910 | |
| GICFIGDLASHKKDK | 406 | Q4G0Z9 | |
| DEQLHCAGKAKRSGG | 236 | Q92731 | |
| GKIAGCSVHKGFAFV | 41 | B2RXH8 | |
| AGGCKHFNLLSSKGA | 121 | Q9BUP3 | |
| KGQKTKSSEDGCKHG | 366 | Q9UJA3 | |
| GKIAGCSVHKGFAFV | 41 | B7ZW38 | |
| ICGAYGKNTLNGHEK | 91 | O76014 | |
| NFHADAELAGKKKGG | 196 | Q9HDC5 | |
| DGAHKTFLKCGALQG | 221 | P16278 | |
| GFGGTGKKSHNKQFD | 166 | Q92499 | |
| GHVKFSKNGKDLGLA | 201 | Q92499 | |
| HCGFKYKLTIVGDGK | 456 | P42262 | |
| TVTLEKCGHNKGYKG | 81 | Q9NXJ5 | |
| GKGDLKCHITANPFK | 126 | Q8TET4 | |
| HGGGLLSSKAKRAKC | 1361 | Q6KC79 | |
| FTKEGCHKKNQSIGL | 136 | Q9UIQ6 | |
| GKIAGCSVHKGFAFV | 41 | P0DMR1 | |
| KVFLVRKAGGHDAGK | 46 | O75676 | |
| KKKTTHFVEGGDAGN | 221 | P18124 | |
| GKGSFGQVAKCLDHK | 111 | Q9NR20 | |
| KEHGNSVCFKVDGGG | 51 | O60741 | |
| GEKKLQCRSDSKGHG | 756 | P20023 | |
| SQCHTVEKGGKHKTG | 16 | P99999 | |
| GNSFKVNSCKDHIGK | 271 | P51587 | |
| DLKEGGKKRFGHICS | 471 | Q8TCT0 | |
| SGLKIQTGKKCDGQF | 471 | Q9HC77 | |
| LHTGKCFCTTKGIKG | 1071 | Q5VV63 | |
| GLYHGQVLCKKNKFG | 341 | P40939 | |
| LNGGCKSQEKRGKSH | 1426 | Q92538 | |
| VKAHGKKVLGAFSDG | 61 | P02042 | |
| VKAHGKKVLGAFSDG | 61 | P68871 | |
| GLAHVACSGHGMKQK | 16 | Q9Y5M1 | |
| CGKGFHQKGNYKNHK | 366 | Q8TBJ5 | |
| KCHGEKGTRIENKLG | 396 | Q5TDP6 | |
| AGCDQIHGAFAKKGV | 1501 | Q5THK1 | |
| AGQMGKHCGKIKTHF | 746 | Q2WGJ9 | |
| DSAGKACGVSVKKGH | 326 | Q6NUM9 | |
| TKASKHGSENKFGKG | 631 | Q5VT97 | |
| HGSENKFGKGKEIIS | 636 | Q5VT97 | |
| QTSEKKFHIGCEKGG | 1441 | Q93008 | |
| KFHIGCEKGGANLIK | 1446 | Q93008 | |
| HTLAAKGDHCRGGKK | 191 | Q17RP2 | |
| KEGVHGGLINKKCYE | 116 | P07737 | |
| THFKGCLGEAFLNGK | 2266 | P25391 | |
| FKHGGTAELKCSQKS | 566 | Q92854 | |
| RKEGNLGTHKAAKGA | 991 | Q9P2P6 | |
| GKKKQHICHIQGCGK | 621 | P08047 | |
| QGLGIIHAYGKKESC | 996 | Q96J65 | |
| GSKNGGDKHGANSLK | 246 | Q96B86 | |
| FGELKEKHKQSGGSV | 366 | O00506 | |
| VGKEASKALGAKGSC | 66 | Q96K30 | |
| AECGKNFGKKTHLVA | 406 | Q9BWE0 | |
| KQSELKGTFKGHKCS | 86 | Q9P126 | |
| EKPGKKSIAACHNVG | 101 | Q96BR5 | |
| QKAGHGKSKGYNRCP | 586 | Q96N96 | |
| CGKAFISGSAFVKHG | 181 | P17039 | |
| GKAFGLCSIFTEHKK | 151 | A8MUV8 | |
| KGCKHVDECTGHKGG | 46 | Q9UII5 | |
| CGKGFGDSSARIKHQ | 576 | Q96MX3 | |
| GTHGHMKCSFDGKLK | 746 | Q2NL82 | |
| KCGKAFGQSSDLLKH | 336 | Q9Y5A6 | |
| HGDKKKEPVNGCNTG | 966 | Q9UBZ9 | |
| LHGKGHTGEKPFKCQ | 281 | Q92670 | |
| QEHCKPSKNGLKGSG | 1206 | Q6IQ55 | |
| GKNCDKFGIVAHELG | 231 | Q9Y6L7 | |
| CGEKPDTHKQRGKAF | 136 | Q96GE5 | |
| SGHHLCKVKALNKGD | 901 | O43847 | |
| IKGKQGKHILYGCSE | 611 | Q8WVM8 | |
| KGVCKEVFQLKGGIH | 371 | Q5T7W7 | |
| KGHKGQEDAVAPGCK | 16 | P0DPA3 | |
| EKKYHFGCEKGGANL | 1446 | O00507 | |
| FGKEFDKHFGKGGSK | 3636 | P78527 | |
| ECGKAFGKGSSLLKH | 331 | Q494X3 | |
| SECGKVFNKKHLLAG | 206 | O43296 | |
| CKSVGEHKVHKGGYN | 116 | O75346 | |
| HSGLKGNKKDVCGKD | 451 | P59923 | |
| HSGQKSFKCEECGKG | 416 | Q9UK13 | |
| GECGKSFSHKGSLVQ | 261 | Q8TF45 | |
| CGEKPDTHKQRGKAF | 136 | Q9Y2A4 | |
| GDLSSFGVAKGKVHC | 1776 | Q9UI33 | |
| QEGCGKHFASPSKLK | 166 | Q92664 | |
| ECGKAFSVKGKLIQH | 396 | P17027 | |
| QALQKGERKKSCGGH | 241 | Q9NV66 | |
| GDYNGHVGLGVKCSK | 131 | P15880 | |
| IGGKGCGKTVIAKNF | 446 | A3KMH1 | |
| KFEKCGHGNLHFKKG | 111 | Q96H40 | |
| QAKKNGSDCGSLGKK | 146 | Q9Y6Q3 | |
| GSDCGSLGKKNNLHK | 151 | Q9Y6Q3 | |
| HTGKKFQKCGECGKT | 266 | O14628 | |
| KGGEQKGHDKISASF | 71 | A0A087WSZ9 |